UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

Human mutation, 2004-07, Vol.24 (1), p.21-34

2004

Volltextzugriff (PDF)

Lack of Independent Prognostic Significance of p21 and p27 Expression in Advanced Ovarian Cancer: An Immunohistochemical Study

Clinical cancer research, 1999-10, Vol.5 (10), p.2848-2853

1999

Volltextzugriff (PDF)

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

Human mutation, 2006-02, Vol.27 (2), p.209-210

2006

Volltextzugriff (PDF)

MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells

Diagnostic cytopathology, 2007-12, Vol.35 (12), p.756-760

2007

Volltextzugriff (PDF)

Hormonal treatment of endometrial carcinoma

Expert review of anticancer therapy, 2002-02, Vol.2 (1), p.106-112

Baekelandt, Mark

2002

Volltextzugriff (PDF)

Carcinoma of the fallopian tube: Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital

Cancer, 2000-11, Vol.89 (10), p.2076-2084

2000

Volltextzugriff (PDF)

Challenging Drug Resistance in Cancer Therapy: Review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997

Acta oncologica, 1998, Vol.37 (5), p.431-439

Gustav Lehne, Erkki Elonen, Mark Baekelandt, Torben Skovsgaard, Curt Peterson

1998

Volltextzugriff (PDF)

Irofulven (MGI Pharma)

Current opinion in investigational drugs (London, England : 2000), 2002-10, Vol.3 (10), p.1517

Baekelandt, Mark

2002

Volltextzugriff (PDF)

P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

Anticancer research, 2000-03, Vol.20 (2B), p.1061

2000

Volltextzugriff (PDF)

The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions

Clinical & experimental metastasis, 2004-01, Vol.21 (3), p.191-199

2004

Volltextzugriff (PDF)

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in theTP53 gene on survival in patients with advanced ovarian carcinoma

Human mutation, 2006-02, Vol.27 (2), p.209-210

2006

Volltextzugriff (PDF)

Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

Anticancer research, 1999-09, Vol.19 (5C), p.4469

1999

Volltextzugriff (PDF)

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma: TP53 VARIATION AND ADVANCED OVARIAN CANCER

Human mutation, 2004-07, Vol.24 (1), p.21-34

2004

Volltextzugriff (PDF)

Carcinoma of the fallopian tube

Cancer, 2000-11, Vol.89 (10), p.2076-2084

2000

Volltextzugriff (PDF)

Borderlinetumorer i ovariene

Tidsskrift for den Norske Lægeforening, 2000-09, Vol.120 (23)

2000

Volltextzugriff (PDF)

DNA-ploiditet ved epitelial ovarialkreft - en uavhengig prognostisk faktor

Tidsskrift for den Norske Lægeforening, 2000, Vol.120 (1)

2000

Volltextzugriff (PDF)

Kontroverser ved kirurgisk behandling av avansert ovarialcancer

Tidsskrift for den Norske Lægeforening, 2000, Vol.120 (7)

2000

Volltextzugriff (PDF)

Chapter 23 - Treatment of Recurrent Uterine Sarcomas

Gynecologic Cancer, p.317-323

Volltextzugriff (PDF)

Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle

Biochemical journal, 2013-11, Vol.456 (1), p.119-128

2013

Volltextzugriff (PDF)

The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation

The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16906-16914

2008

Volltextzugriff (PDF)

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Molecular neurodegeneration, 2018-01, Vol.13 (1), p.3-3, Article 3

2018

Volltextzugriff (PDF)

Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression

European urology open science (Online), 2024-08, Vol.66, p.67-74

2024

Volltextzugriff (PDF)

Differential protein–protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways

Journal of neurochemistry, 2014-10, Vol.131 (2), p.239-250

2014

Volltextzugriff (PDF)

Metaverse in surgery — origins and future potential

Nature reviews. Urology, 2024-09

2024

Volltextzugriff (PDF)

Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain

Journal of neurochemistry, 2015-12, Vol.135 (6), p.1242-1256

2015

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(30)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Female
(8)
Oncology
(8)
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
(6)
Ovarian Neoplasms - Pathology
(6)
Prognosis
(6)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Middle Aged
(5)
Mutation
(5)
Ovarian Neoplasms - Mortality
(5)
Parkinson's Disease
(5)
Adult
(4)
Aged
(4)
Biological And Medical Sciences
(4)
Immunohistochemistry
(4)
Lrrk2
(4)
Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

Lack of Independent Prognostic Significance of p21 and p27 Expression in Advanced Ovarian Cancer: An Immunohistochemical Study

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells

Hormonal treatment of endometrial carcinoma

Carcinoma of the fallopian tube: Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital

Challenging Drug Resistance in Cancer Therapy: Review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997

Irofulven (MGI Pharma)

P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in theTP53 gene on survival in patients with advanced ovarian carcinoma

Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma: TP53 VARIATION AND ADVANCED OVARIAN CANCER

Carcinoma of the fallopian tube

Borderlinetumorer i ovariene

DNA-ploiditet ved epitelial ovarialkreft - en uavhengig prognostisk faktor

Kontroverser ved kirurgisk behandling av avansert ovarialcancer

Chapter 23 - Treatment of Recurrent Uterine Sarcomas

Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle

The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression

Differential protein–protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways

Metaverse in surgery — origins and future potential

Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain

Aktive Filter

Suchergebnisse filtern